downramper's delights: ept, lum and cce

Three stocks in transition and not always understood or not always wanting to be understood.

Three stocks who are in a very interesting phase: the development phase, where they are most sensitive to downrampers.

It is here where the promised goods are yet out of reach of the Investor, something the Downramper loves to make use of.

Here are the three:

EPT: waiting for a FDA clearance; excellent results from Phase II trials but the full preliminary report yet to appear.
Queensland trial involving implantation to start up shortly.

LUM: Several contracts signed lately; waiting for Rod Sala to return and for any news prior to the Annual Meeting.
The focus still is on the Times Square sites to which the Lum consortium have exclusive rights. There are of course other contracts to consider as well.

CCE: Financially somewhat mismanaged in the beginning, but has now a new CEO, who is approachable. Consolidating.

Have started moving into Europe by selection of the Manufacturing facility and is now appointing Distributors.
Europe has no statutory entity which can give Approvals, so each country has to be approached.

I calculated that Cash wil be more than sufficient to last till CCE will be in profit. CEO confirms that cash will last till profitability has been achieved.

Gerry